Identification of HLA-A24-restricted novel T cell epitope peptides derived from P-cadherin and kinesin family member 20A

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Osawa, Ryuji ^a,b   Tsunoda, Takuya ^a,b,c   Yoshimura, Sachiko ^a,b   Watanabe, Tomohisa ^b   Miyazawa, Motoki ^a   Tani, Masaji ^a   Takeda, Kazuyoshi ^d   Nakagawa, Hidewaki ^c   Nakamura, Yusuke ^c   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Research and Development Division   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; GAMMA INTERFERON; HLA A24 ANTIGEN; KINESIN; P CADHERIN; CADHERIN; CDH3 PROTEIN, HUMAN; EPITOPE; KIF20A PROTEIN, HUMAN; PEPTIDE;

ARTICLE; CANCER CELL; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PANCREAS CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CELL STRAIN COS1; CELL SURVIVAL; CERCOPITHECUS; CHEMISTRY; IMMUNOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; CADHERINS; CELL LINE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; EPITOPES, T-LYMPHOCYTE; HLA-A24 ANTIGEN; HUMANS; INTERFERON-GAMMA; KINESIN; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84863653288     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/848042     Document Type: Article

References (30)

1. Boon T., Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy International Journal of Cancer 1993 54 2 177 180 (Pubitemid 23154877)
2. Boon T., Van der Bruggen P., Human tumor antigens recognized by T lymphocytes Journal of Experimental Medicine 1996 183 3 725 729 (Pubitemid 26113944)
3. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van Den Eynde B., Knuth A., Boon T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 1991 254 5038 1643 1647 (Pubitemid 21917508)
4. Brichard V., Van Pel A., Wolfel T., Wolfel C., De Plaen E., Lethe B., Coulie P., Boon T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas Journal of Experimental Medicine 1993 178 2 489 495 (Pubitemid 23218197)
5. Kawakami Y., Eliyahu S., Sakaguchi K., Robbins P. F., Rivoltini L., Yannelli J. R., Appella E., Rosenberg S. A., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes Journal of Experimental Medicine 1994 180 1 347 352 (Pubitemid 24181083)
6. Chen Y. T., Scanlan M. J., Sahin U., Treci.., Gure A. O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., Old L. J., A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening Proceedings of the National Academy of Sciences of the United States of America 1997 94 5 1914 1918 (Pubitemid 27113936)
7. Reynolds S. R., Zeleniuch-Jacquotte A., Shapiro R. L., Roses D. F., Harris M. N., Johnston D., Bystryn J. C., Vaccine-induced CD8 + T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma Clinical Cancer Research 2003 9 2 657 662 (Pubitemid 36187383)
8. Rosenberg S. A., Yang J. C., Schwartzentruber D. J., Hwu P., Topalian S. L., Sherry R. M., Restifo N. P., Wunderlich J. R., Seipp C. A., Rogers-Freezer L., Morton K. E., Mavroukakis S. A., Gritz L., Panicali D. L., White D. E., Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma Clinical Cancer Research 2003 9 8 2973 2980 (Pubitemid 36993255)
9. Pecher G., Hring A., Kaiser L., Thiel E., Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial Cancer Immunology, Immunotherapy 2002 51 11-12 669 673 (Pubitemid 35446294)
10. Miyazawa M., Ohsawa R., Tsunoda T., Hirono S., Kawai M., Tani M., Nakamura Y., Yamaue H., Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer Cancer Science 2010 101 2 433 439
11. Kono K., Mizukami Y., Daigo Y., Takano A., Masuda K., Yoshida K., Tsunoda T., Kawaguchi Y., Nakamura Y., Fujii H., Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer Cancer Science 2009 100 8 1502 1509
12. Okuno K., Sugiura F., Hida J. I., Tokoro T., Ishimaru E., Sukegawa Y., Ueda K., Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer Experimental and Therapeutic Medicine 2011 2 1 73 79
13. Palmer M., Parker J., Modi S., Butts C., Smylie M., Meikle A., Kehoe M., MacLean G., Longenecker M., Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer Clinical Lung Cancer 2001 3 1 49 57 (Pubitemid 32904315)
14. Nakamura T., Furukawa Y., Nakagawa H., Tsunoda T., Ohigashi H., Murata K., Ishikawa O., Ohgaki K., Kashimura N., Miyamoto M., Hirano S., Kondo S., Katoh H., Nakamura Y., Katagiri T., Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection Oncogene 2004 23 13 2385 2400 (Pubitemid 38496794)
15. Taniuchi K., Nakagawa H., Hosokawa M., Nakamura T., Eguchi H., Ohigashi H., Ishikawa O., Katagiri T., Nakamura Y., Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating Rho-family GTPases Cancer Research 2005 65 8 3092 3099 (Pubitemid 40524589)
16. Taniuchi K., Nakagawa H., Nakamura T., Eguchi H., Ohigashi H., Ishikawa O., Katagiri T., Nakamura Y., Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell Cancer Research 2005 65 1 105 112 (Pubitemid 40070801)
17. Takeichi M., The cadherins: cell-cell adhesion molecules controlling animal morphogenesis Development 1988 102 4 639 655
18. Lai F., Fernald A. A., Zhao N., Le Beau M. M., cDNA cloning, expression pattern, genomic structure and chromosomal location of RAB6KIFL, a human kinesin-like gene Gene 2000 248 1-2 117 125 (Pubitemid 30259207)
19. Ikeda-Moore Y., Tomiyama H., Miwa K., Oka S., Iwamoto A., Kaneko Y., Takiguchi M., Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1 Journal of Immunology 1997 159 12 6242 6252 (Pubitemid 127471566)
20. Celis E., Tsai V., Crimi C., DeMars R., Wentworth P. A., Chesnut R. W., Grey H. M., Sette A., Serra H. M., Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes Proceedings of the National Academy of Sciences of the United States of America 1994 91 6 2105 2109 (Pubitemid 24092051)
21. Ishizaki H., Tsunoda T., Wada S., Yamauchi M., Shibuya M., Tahara H., Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1 Clinical Cancer Research 2006 12 19 5841 5849 (Pubitemid 44629617)
22. Uchida N., Tsunoda T., Wada S., Furukawa Y., Nakamura Y., Tahara H., Ring finger protein 43 as a new target for cancer immunotherapy Clinical Cancer Research 2004 10 24 8577 8586 (Pubitemid 40053425)
23. Wada S., Tsunoda T., Baba T., Primus F. J., Kuwano H., Shibuya M., Tahara H., Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2 Cancer Research 2005 65 11 4939 4946 (Pubitemid 40740834)
24. Suda T., Tsunoda T., Daigo Y., Nakamura Y., Tahara H., Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy Cancer Science 2007 98 11 1803 1808 (Pubitemid 47489730)
25. Takeda K., Yamaguchi N., Akiba H., Kojima Y., Hayakawa Y., Tanner J. E., Sayers T. J., Seki N., Okumura K., Yagita H., Smyth M. J., Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy Journal of Experimental Medicine 2004 199 4 437 448 (Pubitemid 38233828)
26. Sultana A., Tudur Smith C., Cunningham D., Starling N., Tait D., Neoptolemos J. P., Ghaneh P., Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy British Journal of Cancer 2007 96 8 1183 1190 (Pubitemid 46625082)
27. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009 CA Cancer Journal for Clinicians 2009 59 4 225 249
28. Imai K., Hirata S., Irie A., Senju S., Ikuta Y., Yokomine K., Harao M., Inoue M., Tsunoda T., Nakatsuru S., Nakagawa H., Nakamura Y., Baba H., Nishimura Y., Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers Clinical Cancer Research 2008 14 20 6487 6495
29. Imai K., Hirata S., Irie A., Senju S., Ikuta Y., Yokomine K., Harao M., Inoue M., Tomita Y., Tsunoda T., Nakagawa H., Nakamura Y., Baba H., Nishimura Y., Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer British Journal of Cancer 2011 104 2 300 307
30. Sampson J. H., Heimberger A. B., Archer G. E., Aldape K. D., Friedman A. H., Friedman H. S., Gilbert M. R., Herndon J. E., McLendon R. E., Mitchell D. A., Reardon D. A., Sawaya R., Schmittling R. J., Shi W., Vredenburgh J. J., Bigner D. D., Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma Journal of Clinical Oncology 2010 28 31 4722 4729